Biological and pharmacokinetic properties of a novel immunoglobulin-CD4 fusion protein
Authors:
- 1 March 1994
- journal article
- research article
- Published by Springer Nature in Archives of Virology
- Vol. 139 (1-2) , 189-196
Abstract
Summary We report a CD4-immunoglobulin fusion protein in which the first two extracellular domains of human CD4 replace the Fc region of the immunoglobulin. When co-expressed with a gene encoding an immunoglobulin light chain, the protein was covalently assembled into a form having an Mr consistent with that expected for two fusion heavy chains and two immunoglobulin light chains. The antigen specificity of the antibody was retained, however, binding to HIV gp120 was lost. Pharmacokinetic analysis revealed the in vivo half-life of the fusion protein to be 2.4 h in mice.Keywords
This publication has 15 references indexed in Scilit:
- HIV interactions with CD4: a continuum of conformations and consequencesImmunology Today, 1992
- Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivoInternational Journal of Cancer, 1992
- Expression and Characterization of Human CD4: Immunoglobulin Fusion ProteinsDNA and Cell Biology, 1990
- Biological properties of a CD4 immunoadhesinNature, 1990
- A CD 4: immunoglobulin fusion protein with antiviral effects against HIVArchives of Virology, 1990
- Designing CD4 immunoadhesins for AIDS therapyNature, 1989
- [32] Production and properties of chimeric antibody molecules1989
- Hybrid immunoglobulin isotypes of identical specificity produced by genetic recombination in Escherichia coli and expression in lymphoid cellsProteins: Structure, Function, and Bioinformatics, 1987
- The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene familyCell, 1985
- Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.Journal of Experimental Medicine, 1985